MarketInOut Stock Screener Log In | Sign Up
 

Axogen Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 05/08/2026
Axogen Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,227.09 mln
Float52.03 mln
Earnings Date08/12/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.76
Likely reliable

1-Year Forecast

50.78
Attractive

Relative Strength

83 / 100
Strongly outperforming

Debt / Equity

0.08
Debt-free

ROE

-22.08
Deeply negative

Business Description

Axogen is a global medical company focused on helping patients recover from peripheral nerve damage through a range of surgical repair products and techniques. Its portfolio includes processed nerve grafts, protective implants, and soft tissue solutions designed to support surgeons in reconnecting and healing injured nerves. The company serves hospitals, surgical centers, and military medical facilities, working with plastic, orthopedic, hand, and oral surgeons through a network of independent distributors. Based in Alachua, Florida, Axogen manages the full process of bringing its nerve repair products to market, from donor tissue recovery and processing to final sterilization and packaging.

Key Fundamentals

EPS-0.64
ROE-22.08
RPS4.89
ROIC-5.63
ROA-13.93
EBITDA, mln-16.56
EV / EBITDA-133
EV / EBIT-86.88
Revenue, mln238
EV / Revenue9.23

Financial Strength

Altman Z-Score29.43
Piotroski F-Score 6 / 9
Beneish M-Score-2.76
Price to Graham Number8.61
1-Year Target Price50.78
Short Ratio3.94
Short % of Float8.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.82% 19 / 100   
1 Month 27.38% 90 / 100   
2 Months 20.69% 86 / 100   
6 Months 79.9% 95 / 100   
1 Year 157% 93 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us